These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 20935658)

  • 1. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
    Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
    Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
    Huang Y; Guo J; Gui S
    Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
    Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
    J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
    Cheng W; Tang C; Yin C
    J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
    Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
    Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.
    Schoellhammer CM; Lauwers GY; Goettel JA; Oberli MA; Cleveland C; Park JY; Minahan D; Chen Y; Anderson DG; Jaklenec A; Snapper SB; Langer R; Traverso G
    Gastroenterology; 2017 Apr; 152(5):1151-1160. PubMed ID: 28088460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
    He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
    Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
    Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
    J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
    He C; Yin L; Tang C; Yin C
    Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
    He C; Yin L; Song Y; Tang C; Yin C
    Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
    Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
    J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
    Zhang M; Wang X; Han MK; Collins JF; Merlin D
    Nanomedicine (Lond); 2017 Aug; 12(16):1927-1943. PubMed ID: 28665164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Ginger-Derived Extracellular Vesicles-Coated ZIF-8 Containing TNF-α siRNA for Ulcerative Colitis Therapy by Modulating Gut Microbiota.
    Cui C; Du M; Zhao Y; Tang J; Liu M; Min G; Chen R; Zhang Q; Sun Z; Weng H
    ACS Appl Mater Interfaces; 2024 Oct; 16(40):53460-53473. PubMed ID: 39303016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.
    Guo Y; He X; Zhao RM; Yang HZ; Huang Z; Zhang J; Yu XQ
    Acta Biomater; 2022 Jul; 147():287-298. PubMed ID: 35489607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
    He C; Yin L; Tang C; Yin C
    Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
    Ball RL; Bajaj P; Whitehead KA
    Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
    Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
    Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A.
    Shrestha P; Duwa R; Lee S; Kwon TK; Jeong JH; Yook S
    Eur J Pharm Sci; 2024 Oct; 201():106856. PubMed ID: 39032536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
    Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
    Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.